COSENZA, Lucia Carmela
 Distribuzione geografica
Continente #
NA - Nord America 3.264
AS - Asia 2.182
EU - Europa 2.084
SA - Sud America 340
AF - Africa 48
OC - Oceania 18
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.938
Nazione #
US - Stati Uniti d'America 3.165
SG - Singapore 866
PL - Polonia 753
CN - Cina 702
IT - Italia 463
BR - Brasile 286
DE - Germania 243
HK - Hong Kong 180
GB - Regno Unito 108
VN - Vietnam 107
FR - Francia 102
FI - Finlandia 76
SE - Svezia 69
RU - Federazione Russa 66
UA - Ucraina 66
ID - Indonesia 64
TR - Turchia 60
CA - Canada 54
IN - India 42
NL - Olanda 35
MX - Messico 34
AR - Argentina 29
IR - Iran 25
JP - Giappone 22
ZA - Sudafrica 22
BE - Belgio 18
IQ - Iraq 17
BD - Bangladesh 16
PK - Pakistan 16
ES - Italia 15
AU - Australia 13
KR - Corea 13
RO - Romania 13
AT - Austria 12
CZ - Repubblica Ceca 12
EC - Ecuador 7
CO - Colombia 6
LT - Lituania 6
MA - Marocco 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
EG - Egitto 4
GR - Grecia 4
JO - Giordania 4
KZ - Kazakistan 4
SD - Sudan 4
UZ - Uzbekistan 4
VE - Venezuela 4
CR - Costa Rica 3
DM - Dominica 3
HU - Ungheria 3
KE - Kenya 3
KW - Kuwait 3
MY - Malesia 3
SA - Arabia Saudita 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
YE - Yemen 3
BG - Bulgaria 2
DZ - Algeria 2
IE - Irlanda 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
LI - Liechtenstein 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.938
Città #
Warsaw 750
Singapore 474
Ashburn 434
Beijing 304
Woodbridge 214
Chandler 206
Fairfield 196
Ann Arbor 191
Santa Clara 190
Hong Kong 180
Ferrara 176
Houston 122
Munich 88
Seattle 87
Dallas 85
Los Angeles 85
Jacksonville 83
Wilmington 77
New York 74
Cambridge 67
Addison 59
Jakarta 55
Shanghai 55
Nanjing 45
Turku 39
Bologna 36
Ho Chi Minh City 36
Milan 36
Princeton 35
Izmir 31
Bremen 30
Redwood City 30
San Diego 24
Hefei 22
Mexico City 22
Brooklyn 21
Toronto 21
Ferrara di Monte Baldo 20
London 20
Orem 20
Boardman 19
São Paulo 19
Brussels 17
Hanoi 17
Johannesburg 17
Rio de Janeiro 17
Buffalo 16
Denver 16
Tokyo 16
Atlanta 15
Chicago 15
Moscow 15
The Dalles 15
Boston 14
Dong Ket 14
Helsinki 14
Shenyang 14
Chennai 13
Montreal 12
Poplar 12
Falkenstein 11
Rome 10
San Jose 10
Stockholm 10
Brno 9
Dearborn 9
Nanchang 9
Nuremberg 9
Phoenix 9
Sydney 9
Varese 9
San Francisco 8
Vienna 8
Washington 8
Zhengzhou 8
Ankara 7
Belo Horizonte 7
Charlotte 7
Columbus 7
Des Moines 7
Falls Church 7
Frankfurt am Main 7
Ottawa 7
Amsterdam 6
Buenos Aires 6
Council Bluffs 6
Curitiba 6
Da Nang 6
Jinan 6
Kunming 6
Napoli 6
New Delhi 6
Paris 6
Yogyakarta 6
Baghdad 5
Cagliari 5
Changsha 5
Jiaxing 5
Lappeenranta 5
Manchester 5
Totale 5.335
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 387
A validated cellular biobank for β-thalassemia 366
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 336
Cellular and biomolecular technologies for stratification of β thalassemia patients: applications in theranostics 325
A validated THALAMOSS cellular biobank for β-thalassemia 292
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 271
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 265
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 252
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 243
SPR-based non-invasive prenatal testing for fetal sex determination 218
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 205
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 203
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 199
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 197
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 185
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 178
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 164
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 162
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 161
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 158
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 153
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis 151
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 151
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 144
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 137
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 131
Analysis of the miRNome as a possible tool for the detection of autologous blood transfusion misuse in sport 128
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 118
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 116
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 116
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 110
null 107
Evidences for miRNA regulation of BCL11A gene expression 104
Targeting miR‑155‑5p and miR‑221‑3p by peptide nucleic acids induces caspase‑3 activation and apoptosis in temozolomide‑resistant T98G glioma cells 103
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 102
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 101
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 100
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study 98
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 97
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic 94
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 91
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 89
Sex-specific transcriptional profiles identified in β-thalassemia patients 85
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin) 84
Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences 81
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 75
null 75
New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients 74
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 71
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 67
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 62
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies 59
The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p 50
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells 44
Anticancer activity of MDM2 inhibition in 2D and bioprinted 3D retinoblastoma cell models 9
Totale 8.144
Categoria #
all - tutte 37.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.905


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021528 0 0 0 0 0 79 72 61 45 101 102 68
2021/2022480 85 31 19 21 24 28 43 25 11 34 26 133
2022/2023512 44 67 15 48 87 51 58 45 48 4 22 23
2023/2024458 15 45 12 10 66 93 43 42 8 9 26 89
2024/20251.645 72 53 139 107 158 152 60 54 296 170 208 176
2025/20262.228 447 153 305 444 625 254 0 0 0 0 0 0
Totale 8.144